Investment
Features
FeesSafety
Academy
More
Pluang+

Compare James Hardie Industries plc. Ordinary Shares (JHX) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

James Hardie Industries plc. Ordinary SharesTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

James Hardie Industries plc. Ordinary Shares vs uniQure N.V. Ordinary Shares — how do they compare? James Hardie Industries plc. Ordinary Shares trades at $24.56 (market cap $14.32B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: James Hardie Industries plc. Ordinary Shares is far larger — about 9.7× uniQure N.V. Ordinary Shares's market cap, and James Hardie Industries plc. Ordinary Shares is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold James Hardie Industries plc. Ordinary Shares for 6 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

JHXQURE
Market Cap
$14.32B$1.48B
Volume
5,683,8202,488,780
Sector
Basic MaterialsHealth
52-Week High
$31.08$70.59
52-Week Low
$16.69$9.03
Typical Hold Time
6 Days0 Days
Enterprise Value
$18.55B$728.62M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

James Hardie Industries plc. Ordinary Shares

James Hardie Industries (JHX) trades at $24.67, down 0.36% with a bearish technical outlook. The stock shows mixed fundamentals with a high P/E ratio of 112.14 but strong revenue growth from $3.88B to $5.4B projected. Recent earnings beat expectations in Q2 2026, and the company completed strategic divestitures including the $980M Fermacell sale to Holcim. Analyst sentiment remains positive with 70.59% buy ratings and a $34 consensus price target representing 38% upside potential.

JHX presents a growth story with expanding revenues but faces profitability compression as net margins decline from 10.93% to 2.69%. The stock's high valuation multiples require strong execution to justify. Key risks include integration challenges from recent acquisitions, rising debt levels, and housing market sensitivity. Institutional ownership shows mixed signals with State Street reducing its position while short interest increased 47.8% in September 2026.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JHX

No sentiment data available yet.

QURE
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About James Hardie Industries plc. Ordinary Shares

James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.

Read more on JHX →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →